Clinical Trials Browser

Lymphoma, T-Cell × Decitabine × 1 year × Clear all

NCT03240211 2025-08-26

Study of Pembrolizumab Combined With Decitabine and Pralatrexate in PTCL and CTCL

Phase 1 Active not recruiting

Lymphoma, T-Cell